Q4 2025 Earnings Call March 18, 2026 4:30 PM EDTCompany ParticipantsMaria Sainz - CEO, President & DirectorBrett Hale - ...
Overall, we have raised a total of $472.2 million in net proceeds from the sale of 12 container vessels since December 2023, and have recycled this capital into our focus on gas transportation assets.
The noninferiority trial of patients at risk for both bleeding and stroke, in a surprise turn, found standard care to be ...
Background: Patients with a transient ischemic attack (TIA) or minor stroke have an increased risk of subsequent stroke that ...
BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced multiple presentations at the American ...
Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that three scientific abstracts highlighting its commercial products VEVYE® ...
Every year, Idaho State University hosts students from across all programs and disciplines to present their research. This includes undergraduate and graduate students, who are judged on their posters ...
Q4 2025 Earnings Call March 18, 2026 8:30 AM EDTCompany ParticipantsMarvin Slosman - President, CEO & DirectorMichael Lawless ...
In 2023, the burden of stroke accounted for approximately 157 million disability-adjusted life years (DALYs), ranking second among all non-communicable diseases globally. Although age-standardised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results